News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Press Releases
Browse the the latest press releases from around the industry. Want to filter press releases by date, keyword, and more? Search
here.
THE LATEST
Press Releases
Bayer® Aspirin Introduces Aspirina to the U.S. Pain Market
August 18, 2025
·
4 min read
Press Releases
Children’s Hospital of Philadelphia Researchers Find that Missing Messenger RNA Fragments Could be Key to New Immunotherapy for Hard-to-Treat Tumors
August 18, 2025
·
5 min read
Press Releases
Grove Biopharma to Participate in Materials Biology Symposium at ACS Fall 2025 Scientific Meeting
August 18, 2025
·
2 min read
Press Releases
Bioxytran Unveils Revolutionary Precision Diagnostics on Tissue Oxygenation
August 18, 2025
·
3 min read
Press Releases
Hope Realized: FDA Approves Papzimeos for Adults with Recurrent Respiratory Papillomatosis (RRP)
August 18, 2025
·
4 min read
Press Releases
Ascelia Pharma Updates Timeline for Submission of the Orviglance NDA
August 18, 2025
·
1 min read
Press Releases
Tonix Pharmaceuticals Announces FDA Approval of Tonmya™ (cyclobenzaprine HCl sublingual tablets) for the Treatment of Fibromyalgia
August 18, 2025
·
15 min read
Press Releases
Jabez Biosciences, Inc. Opens Second Clinical Site in Phase 1 Oncology Clinical Study of JBZ-001
August 18, 2025
·
3 min read
Press Releases
4DMT Announces New Employment Inducement Grants - August 15, 2025
August 18, 2025
·
2 min read
Press Releases
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - August 15, 2025
August 18, 2025
·
3 min read
Press Releases
Children’s Hospital of Philadelphia and Children’s Hospital Colorado Researchers Conduct First Prospective Study of Pediatric EoE Patients and Disease Progression
August 18, 2025
·
5 min read
Press Releases
BioSig Technologies, Inc. & Streamex Announce Closing of $15 Million Public Offering
August 18, 2025
·
4 min read
Press Releases
Allarity Therapeutics Provides Second Quarter 2025 Update, Highlighting Clinical Progress, IP Expansion, and New Partnerships
August 18, 2025
·
13 min read
Press Releases
Novo Nordisk A/S: Wegovy® approved in the US for the treatment of MASH
August 18, 2025
·
4 min read
Press Releases
Ryght AI Partners with Global CRO Biorasi to Deliver AI-Powered Feasibility Solutions to Biotech and Biopharma Sponsors
August 18, 2025
·
4 min read
Press Releases
Wegovy® approved by FDA for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosis
August 18, 2025
·
15 min read
Press Releases
Quest Diagnostics to Speak at the Baird 2025 Global Healthcare Conference
August 18, 2025
·
1 min read
Press Releases
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - August 15, 2025
August 18, 2025
·
3 min read
Press Releases
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - August 15, 2025
August 18, 2025
·
1 min read
Press Releases
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - August 15, 2025
August 18, 2025
·
3 min read
Press Releases
Ascentage Pharma Announces Global Registrational Phase III Study of Lisaftoclax for First-line Treatment of Patients with Higher-Risk Myelodysplastic Syndrome Cleared by US FDA and EMA
August 18, 2025
·
11 min read
Press Releases
Ascletis Announces the Combination of ASC47 and ASC31, its Dual GLP-1R/GIPR Peptide Agonist, Demonstrated Significantly Greater Weight Loss Compared to the Combination of ASC47 and Tirzepatide in an Animal Model of Obesity
August 18, 2025
·
3 min read
Press Releases
Gabby Thomas Partners with Babson Diagnostics’ BetterWay to Promote Accessible Healthcare
Olympic Gold Medalist and Public Health Advocate to Raise Awareness for Routine Blood Testing
August 15, 2025
·
1 min read
Press Releases
Plus Therapeutics Reports Stockholders’ Equity in Excess of $2.5 million in Compliance with Nasdaq Equity Requirements
August 15, 2025
·
2 min read
Press Releases
Exactech Announces CEO Transition
August 19, 2025
·
5 min read
Press Releases
MedImpact Offers Low Cost, Unbranded Ustekinumab-aekn Biosimilar to Any Specialty Pharmacy in the US
August 19, 2025
·
2 min read
Press Releases
Cantargia Appoints Dr Hilde Steineger as Chief Executive Officer
August 19, 2025
·
4 min read
Press Releases
Northwest Biotherapeutics Announces the Passing of Its Senior Vice President and General Counsel, Mr. Les Goldman
August 19, 2025
·
3 min read
Press Releases
Curant Rare Announces Exclusive Pharmacy Partnership for IWILFIN™, the First and Only FDA-Approved Oral Maintenance Therapy Shown to Cut the Risk of High-Risk Neuroblastoma Relapse in Half
August 19, 2025
·
4 min read
Press Releases
Mesa Laboratories Executes Previously-Announced Strategic Financing Plan
August 18, 2025
·
4 min read
Press Releases
Luna Diabetes Raises Series A Financing to Advance its Automated Insulin Delivery Solution For Insulin Pen Users
August 18, 2025
·
3 min read
Press Releases
HCW Biologics Reports Second Quarter 2025 Business Highlights and Financial Results
August 18, 2025
·
14 min read
Press Releases
PCI Biotech announces discontinuation of development of the PCL technology and evaluation of future operations
August 18, 2025
·
2 min read
Press Releases
Resmed Announces Election of Nicole Mowad-Nassar to Board of Directors and Upcoming Retirement of Rich Sulpizio
August 18, 2025
·
3 min read